CAS 864845-15-8

4-Bromo-1,2-dihydro-3H-indazol-3-one

Description:

4-Bromo-1,2-dihydro-3H-indazol-3-one is a chemical compound characterized by its indazole core, which features a bromine substituent at the 4-position and a carbonyl group at the 3-position. This compound typically appears as a solid at room temperature and is soluble in organic solvents, reflecting its relatively non-polar nature due to the presence of the aromatic indazole structure. The bromine atom introduces both steric and electronic effects, which can influence its reactivity and interactions in chemical reactions. The presence of the carbonyl group contributes to its potential as a reactive electrophile, making it useful in various synthetic applications, including medicinal chemistry. Additionally, compounds of this type may exhibit biological activity, making them of interest in drug discovery and development. Safety data should be consulted for handling, as halogenated compounds can pose health risks. Overall, 4-Bromo-1,2-dihydro-3H-indazol-3-one is a versatile compound with applications in research and industry.

Formula: C₇H₅BrN₂O

InChI: InChI=1S/C7H5BrN2O/c8-4-2-1-3-5-6(4)7(11)10-9-5/h1-3H,(H2,9,10,11)

SMILES: c1cc(c2c(c1)[nH]nc2O)Br

Synonyms:

• 3H-Indazol-3-one, 4-bromo-1,2-dihydro-

4-Bromo-1H-indazol-3(2H)-one

CAS: 864845-15-8

Formula: C₇H₅BrN₂O

Purity: 97%

Color and Shape: Solid

Molecular weight: 213.0314

Ref: IN-DA003KUW

4-Bromo-1,2-dihydro-3H-indazol-3-one

CAS: 864845-15-8

4-Bromo-1,2-dihydro-3H-indazol-3-one

Purity: 98%

Molecular weight: 213.03g/mol

Ref: 54-OR305558

4-Bromo-1H-indazol-3(2H)-one

CAS: 864845-15-8

Formula: C₇H₅BrN₂O

Purity: 97%

Color and Shape: Solid

Molecular weight: 213.034

Ref: 10-F337492

4-bromo-1h-indazol-3(2h)-one

CAS: 864845-15-8

Remogliflozin is a potent inhibitor of the activity of the enzyme sglt2, which is involved in the regulation of glucose and lipid metabolism. Remogliflozin etabonate is an orally active metabolite that has been shown to inhibit sglt2 in mice with high oral bioavailability. This metabolite can be used as a lead compound for the discovery of novel drugs for diabetes and obesity treatment.

Formula: C₇H₅BrN₂O

Purity: Min. 95%

Molecular weight: 213.03 g/mol

Ref: 3D-PJB84515